Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Segment Information (Details)

v3.19.3.a.u2
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Net revenues - External $ 4,061,189 $ 3,292,217 $ 9,251,839 $ 4,893,877  
(Loss) income from continuing operations before income taxes: (13,279,576) 45,464,498 (26,212,371) (101,321,801)  
Depreciation and amortization 186,236 317,734 409,822 651,248  
Capital expenditures 1,398 43,715  
Total assets 16,928,195   16,928,195   $ 14,199,300
Hospital Operations [Member]          
Net revenues - External 4,055,774 3,177,481 9,161,039 4,733,556  
(Loss) income from continuing operations before income taxes: (4,002,213) (1,231,764) (7,177,320) (2,704,363)  
Depreciation and amortization 176,371 99,991 350,147 137,717  
Capital expenditures 1,398 43,715  
Total assets 16,257,398   16,257,398   13,568,933
Clinical Laboratory Operations [Member]          
Net revenues - External 5,415 114,736 90,800 160,321  
(Loss) income from continuing operations before income taxes: (180,028) (462,271) (405,558) (1,218,354)  
Depreciation and amortization 9,683 217,495 59,345 512,969  
Capital expenditures  
Total assets 425,167   425,167   271,426
Corporate [Member]          
(Loss) income from continuing operations before income taxes: (914,074) (699,350) (1,986,909) (2,182,691)  
Depreciation and amortization 182 248 330 562  
Total assets 2,687,282   2,687,282   2,707,416
Other Income (Expense), Net [Member]          
(Loss) income from continuing operations before income taxes: (8,183,261) $ 47,857,883 (16,642,584) $ (95,216,393)  
Assets of AMSG And HTS Classified as Held for Sale [Member]          
Total assets 318,854   318,854   152,171
Eliminations [Member]          
Total assets $ (2,760,506)   $ (2,760,506)   $ (2,500,646)